Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia

Abstract

Apaf-1 protein deficiency occurs in human leukaemic blasts and confers resistance to cytochrome-c-dependent apoptosis. Demethylation treatment with 5-aza-2′-deoxycytidine (5aza2dc) increased the sensitivity of the K562 leukaemic cell line to UV light-induced apoptosis in association with increased Apaf-1 protein levels. There was no correlation between Apaf-1 protein expression and Apaf-1 mRNA levels after the demethylation treatment. Methylation-specific polymerase chain reaction was used to show that the methylation can occur within the Apaf-1 promoter region in leukaemic blasts. Apaf-1 DNA methylation was demonstrated in acute myeloid leukaemia, chronic myeloid leukaemia and acute lymphoid leukaemia, suggesting that it is not specific to a particular leukaemia subtype. Apaf-1 protein expression did not correlate with Apaf-1 mRNA levels in human leukaemic blasts. Some leukaemic cells expressed high levels of Apaf-1 mRNA but low levels of Apaf-1 protein. This study suggests that Apaf-1 DNA promoter methylation might contribute to the inactivation of Apaf-1 expression. However, Apaf-1 protein levels might also be controlled at post-transcription level.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Baylin SB and Herman JG . (2000). DNA Trends Genet., 16, 168–174.

  • Chitnis S, Monteiro J, Glass D, Apatoff B, Salmon J, Concannon P and Gregersen PK (2000). Arthritis Res., 2, 399–406.

  • Feinberg AP . (2001). Proc. Natl. Acad. Sci. USA, 98, 392–394.

  • Fu WN, Kelsey SM, Newland AC and Jia L . (2001). Biochem. Biophys. Res. Commun., 282, 268–272.

  • Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B and Debatin KM . (2001). Oncogene, 20, 5865–5877.

  • Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB . (1996). Proc. Natl. Acad. Sci. USA, 93, 9821–9826.

  • Jia L, Patwari Y, Srinivasula SM, Newland AC, Fernandes-Alnemri T, Alnemri ES and Kelsey SM . (2001a). Oncogene, 20, 4817–4826.

  • Jia L, Srinivasula SM, Liu FT, Newland AC, Fernandes-Alnemri T, Alnemri ES and Kelsey SM . (2001b). Blood, 98, 414–421.

  • Jones PA . (2001). Nature, 409, 141–144.

  • Laird PW and Jaenisch R . (1994). Hum. Mol. Genet., 3, 1487–1495.

  • Li E, Bestor TH and Jaenisch R . (1992). Cell, 69, 915–926.

  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X . (1997). Cell, 91, 479–489.

  • Liu FT, Kelsey SM, Newland AC and Jia L . (2002). Br. J. Haematol., 117, 333–342.

  • Lopatina N, Haskell JF, Andrews LG, Poole JC, Saldanha S and Tollefsbol T . (2002). J. Cell Biochem., 84, 324–334.

  • Perkins C, Kim CN, Fang G and Bhalla KN . (1998). Cancer Res., 58, 4561–4566.

  • Rountree MR, Bachman KE, Herman JG, and Baylin SB . (2001). Oncogene, 20, 3156–3165.

  • Shinoura N, Sakurai S, Asai A, Kirino T and Hamada H . (2001). Int. J. Cancer, 93, 252–261.

  • Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW and Lowe SW . (1999). Science, 284, 156–159.

  • Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C and Lowe SW . (2001). Nature, 409, 207–211.

  • van Noesel MM, van Bezouw S, Salomons GS, Voute PA, Pieters R, Baylin SB, Herman JG and Versteeg R . (2002). Cancer Res., 62, 2157–2161.

  • Wolf BB, Schuler M, Li W, Eggers-Sedlet B, Lee W, Tailor P, Fitzgerald P, Mills GB and Green DR . (2001). J. Biol. Chem., 276, 34244–34251.

  • Zou H, Henzel WJ, Liu X, Lutschg A and Wang X . (1997). Cell, 90, 405–413.

Download references

Acknowledgements

We are pleased to acknowledge the Cancer Research UK Medical Oncology Unit for collection and storage of peripheral blood, Dr Jude Fitzgibbon for reading the manuscript, and Mr Gary Wright for helping in DNA sequencing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li Jia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fu, WN., Bertoni, F., Kelsey, S. et al. Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia. Oncogene 22, 451–455 (2003). https://doi.org/10.1038/sj.onc.1206147

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206147

Keywords

This article is cited by

Search

Quick links